Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-02-06

Clinical Trial Update: Impact of Vitamin D Supplementation on Hepcidin Levels and Transfusion Requirements in Surgical and Septic Patients [NA]

View source ↗

Summary

This clinical trial update investigates whether vitamin D supplementation affects hepcidin levels and transfusion requirements in surgical and septic patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D3 (Cholecalciferol) (Cholecalciferol)

Snippet

Sponsor: Iuliu Hatieganu University of Medicine and Pharmacy | Conditions: Systemic Inflammatory Response Syndrome, Sepsis | NA | Status: UNKNOWN